Groove Financial Statements From 2010 to 2024
GRVE Stock | USD 0 0.0005 9.26% |
Check Groove Botanicals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Groove Botanicals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Groove financial statements analysis is a perfect complement when working with Groove Botanicals Valuation or Volatility modules.
Groove |
Groove Botanicals Company Current Valuation Analysis
Groove Botanicals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Groove Botanicals Current Valuation | 1.41 M |
Most of Groove Botanicals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Groove Botanicals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Groove Botanicals has a Current Valuation of 1.41 M. This is 99.99% lower than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Groove Botanicals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Groove Botanicals's current stock value. Our valuation model uses many indicators to compare Groove Botanicals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Groove Botanicals competition to find correlations between indicators driving Groove Botanicals's intrinsic value. More Info.Groove Botanicals is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Groove Botanicals' earnings, one of the primary drivers of an investment's value.About Groove Botanicals Financial Statements
Groove Botanicals stakeholders use historical fundamental indicators, such as Groove Botanicals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Groove Botanicals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Groove Botanicals' assets and liabilities are reflected in the revenues and expenses on Groove Botanicals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Groove Botanicals. Please read more on our technical analysis and fundamental analysis pages.
The company was formerly known as Avalon Oil Gas, Inc. and changed its name to Groove Botanicals, Inc. in May 2018. Groove Botanicals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Groove Pink Sheet
Groove Botanicals financial ratios help investors to determine whether Groove Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Groove with respect to the benefits of owning Groove Botanicals security.